Cargando…

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. The Hippo signaling pathway has emerged as a significant suppressive pathway for hepatocellular carcinogenesis. The core components of the Hippo pathway constitute a kinase cascade, which inhibits the functional activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dongyi, Li, Quanhui, Zang, Yifeng, Li, Xin, Li, Zhongbo, Zhang, Peng, Feng, Chang, Yang, Penghe, Cui, Jiayao, Sun, Yanan, Wei, Tian, Su, Peng, Zhao, Xin, Yang, Huijie, Ding, Yinlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090121/ https://www.ncbi.nlm.nih.gov/pubmed/37041150 http://dx.doi.org/10.1038/s41419-023-05777-1

Ejemplares similares

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
por: Wang, Tianshi, et al.
Publicado: (2023)

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
por: Wang, Dehai, et al.
Publicado: (2022)

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer
por: Yan, Cheng, et al.
Publicado: (2022)

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway
por: Yang, Rui, et al.
Publicado: (2016)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling
por: Liu, Yun, et al.
Publicado: (2021)

The effector of Hippo signaling, Taz, is required for formation of the micropyle and fertilization in zebrafish
por: Yi, Xiaogui, et al.
Publicado: (2019)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis
por: Mi, Yushuai, et al.
Publicado: (2022)

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis
por: Wang, Haichuan, et al.
Publicado: (2020)

The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
por: Rognoni, Emanuel, et al.
Publicado: (2019)

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
por: Hillmer, Ryan E., et al.
Publicado: (2019)

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
por: Lu, Li, et al.
Publicado: (2018)

High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019)

The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
por: Zhu, Jian, et al.
Publicado: (2020)

Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology
por: Chen, Xiaoqing, et al.
Publicado: (2020)

USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ
por: Yuan, Putao, et al.
Publicado: (2022)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla, et al.
Publicado: (2016)

RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation
por: Ding, Kaikai, et al.
Publicado: (2019)

Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ
por: Khanal, Prem, et al.
Publicado: (2018)

Molecular Mechanism of Hippo–YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration
por: Chen, Xiaoqing, et al.
Publicado: (2020)

The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ
por: Li, Jin, et al.
Publicado: (2022)

Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
por: Sun, Xiaohan, et al.
Publicado: (2019)

The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
por: Benedetto, Anna Di, et al.
Publicado: (2016)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2022)

USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ
por: Tang, Jianing, et al.
Publicado: (2022)

Ginsenosides Regulates Innate Immunity to Affect Immune Microenvironment of AIH Through Hippo-YAP/TAZ Signaling Pathway
por: Zhang, Kehui, et al.
Publicado: (2022)

The Hippo Signaling Transducer TAZ Regulates Mammary Gland Morphogenesis and Carcinogen-induced Mammary Tumorigenesis
por: Denson, Kayla E., et al.
Publicado: (2018)

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
por: Moroishi, Toshiro, et al.
Publicado: (2015)

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
por: Kedan, Amir, et al.
Publicado: (2018)

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
por: Isfort, Ilka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lhh9c460g156qqepmroolceeu8